Professional Documents
Culture Documents
Epidemiology of Hypertension
Epidemiology of Hypertension
HYPERTENSION
Mrs.Elavarasi.R
Professor,
Dept.of Community Health Nursing
IQ City Institute of Nursing sciences
1
HYPERTENSION
2
A
SILENT
KILLER
3
• Hypertension is a silent, invisible killer that
rarely causes symptoms.
• Increasing public awareness is key, as is
access to early detection.
• Raised blood pressure is a serious
warning sign that significant lifestyle
changes are urgently needed.
• People need to know why raised blood
pressure is dangerous, and how to take
steps to control it.
4
5
Hypertension is defined as a systolic
blood pressure equal to or above 140 mm
Hg and/or diastolic blood pressure equal
to or above 90 mm Hg
6
History of
History of
Hypertension
7
Historical of hypertension records as far
back as 2600 B.C. hold mention of “hard
pulse disease”
First treatments: Leeching/phlebotomy,
acupuncture
Hippocrates recommended phlebotomy
120 AD – cupping of the spine to
draw animal spirits down and out
was recommended
8
Lithograph showing the leeching of a patient. 9
No way to measure prior to
1700s
11
1905 – N.C. Korotkoff reported on the
method of auscultation of brachial artery, the
method which is widely used today
Allowed auscultation of diastolic BP as well
12
WHO/ISH CLASSIFICATION
OF BLOOD PRESSURE
*JNC-7 14
Seated quietly for 5 minutes
Appropriate size cuff
Inflate 20-30 mmHg above loss of radial
pulse.Deflate at 2mmHg per second
1st sound SBP ; Disappearance of Korotkoff
sound (phase 5) is DBP.
– Confirm Elevated blood pressure within
2months(stage 1) –shorter for stage 2 if
new onset
*JNC-7
15
Globally cardiovascular disease
accounts for approximately 17
million deaths a year, nearly one
third of the total deaths. Of these,
complications of hypertension
account for 9.4 million deaths
worldwide every year .
Hypertension is responsible for at
least 45% of deaths due to heart
disease and 51% of deaths due to
stroke .
16
In terms of attributable
deaths, hypertension is one
of the leading behavioral and
physiological risk factor to
which 13% of global deaths
are attributed.
Hypertension is reported
to be the fourth
contributorto
premature death in developed
countries and
seventh in the developing
countries.
17
Recent reports indicate that nearly
1 billion adults (more than
a quarter of the world’s
population)
had hypertension in 2000,
and this is increase
predictedto
to
1.56 billion by 2025.
Highest prevalence is in• Highest prevalence will be in
established market developing continents
economies (eg, North (eg, Asia, Africa) will account
America, Europe) for 75% of world’s
Kearney PM et al. Lancet. 2005;365:217-223. hypertensive patients 19
Recent studies from India have shown the
prevalence of HTN to be 25% in urban and 10% in
rural people in India .
Secondary Hypertension
- Elevated BP with a specific
cause - 5% to 10% in
adults
22
NON-MODIFIABLE
Age (> 55 for men; > 65 for women)
Gender
Family history
23
a) Alcohol
b) Cigarette smoking
c) Diabetes mellitus
d) Elevated serum lipids
e) Excess dietary sodium
f) Obesity (BMI > 30)
g) Sedentary lifestyle
h) Socioeconomic status
i) Stress
24
Frequently asymptomatic until severe and
target organ disease has occurred
25
§ Sleepapnea
§ Drug-induced or related causes
§ Primary aldosteronism
§ Renovascular disease
26
The pathogenesis
of primary
hypertension is still
unclear.
27
a. Genetic factors
b. Sodium intake
c. Renin- agiotensin
systems
d. Sympathetic nervous
system
e. Endothelial
dysfunction
f. Insulin resistance
g. Other factors
28
The off springs of the
hypertensive
parents are more
prone to suffer
from essential
hypertension
compared with that
without hypertensive
family.
29
The mechanisms
leading to
hypertension are
due to increased
blood volume and
the content of the
sodium in the
smooth muscle cells
enhance following
subsequent calcium
increase.
30
The activation
of Sympathetic
nervous can
augment periphery
resistant which
increase systemic
arterial pressure.
31
Obesity
Smoking
Intake alcohol
OSAS
Low calcium ,
magnesium and
potassium.
32
Systemic atherosclerosis
develops with increased
intimal-medium
thickness leading to
ischemic alterations in
target organs such as
heart, brain, kidney and
peripheral artery.
33
In Aorta and large
arteries recurrent
pulsatile stress
produces
disruption uncoiling,
and
calcification of elastic
fibres. At the
same time, relatively
inelastic collagen
is also increased.
34
This is a result of
ageing as well as
hypertension : both
processes
therefore cause
loss of the normal
elastic reservoir
funtion of arteries.
35
Hypertensive Heart Disease/ Coronary
artery disease
Left ventricular hypertrophy/ Heart
failure
Cerebro-vascular Disease/ Stroke
Peripheral Vascular Disease
Nephrosclerosis/nephropathies
Retinal Damage
Hypertensive emergencies
Dissection of aorta
36
§ Routine Tests
• Electrocardiogram
• Urinalysis / Blood glucose, and hematocrit
• Serum potassium, creatinine, or the
corresponding estimated GFR, and calcium
• Lipid profile, after 9- to 12-hour fast, that includes
high- density and low-density lipoprotein cholesterol,
and triglycerides
§ Optionaltests - Measurement of urinary albumin
excretion or albumin/creatinine ratio
§ Moreextensive testing for identifiable causes is not
generally indicated unless BP control is not being
achieved.
37
40
JNC-8 :TREATMENT CHOICES
41
PREVENTION
OF
42
Hypertension can be prevented by
complementary application of strategies
that target the general population and
individuals and groups at higher risk for
high blood pressure.
However, prevention strategies applied
early in life provide the greatest long-term
potential for reducing the overall burden of
blood pressure related complications in the
community
43
A population-based approach
aimed at achieving a downward
shift in the distribution of blood
pressure in the general population
and is an important component for
any comprehensive plan to prevent
hypertension.
44
Average Percent Reduction
Stroke incidence
35–40%
Myocardial infarction
20–25%
Heart failure
50%
45
In an analysis based on Framingham
Heart Study experience, Cook et al.
concluded that a 2 mmHg reduction in
the population average of diastolic
blood pressure for white U.S.
residents 35 to 64 years of age would
result in a 17 percent decrease in the
prevalence of hypertension, a 14
percent reduction in the risk of stroke
and transient ischemic attacks, and a 6
percent reduction in the risk of CHD
46
BP Reductions as Small as 2 mmHg Reduces the Risk
of CV Events by Up to 10%
▶ Meta-analysis of 61 prospective, observational
studies
▶ 1 million adults
▶ 12.7 million person- 10% increase in
years stroke Mortality
risk
2 mmHg
increase in
mean SBP
7% increase in risk
of IHD Mortality
47
Public health approaches,
such lowering sodium
as
content or caloric density in
the food supply and
providing ,
and convenient
attractive, safe,
opportunities for exercise
are ideal population-based
approaches for reduction of
average blood pressure in
the community
48
More intensive targeted approaches, aimed at
achieving a greater reduction in blood pressure in those
who are most likely to develop hypertension.
49
52
53
54
The Connection
55
Sodium, through hypertension, is a major contributor to
death, disability, disparities, and costs attributable to
cardiovascular diseases (CVD)
Globally, 8.5 million deaths could be averted over 10
years from 2006 to 2015 through a 15% reduction in
sodium intake
An adults should consume less than 2000
milligrams of sodium, or 5 g of salt per day
57
WHO recommends that adults
should consume at least 3,510
mg of potassium/day.
58
How public health
stakeholders
can tackle
hypertension?
59
There are six important components of any
country
6|monitoring of progress.
60
Integrated programmes must be
established at the primary care
level for control of hypertension.
In most countries thisis the
weakest level the
of system. health
61
The cumulative cost of implementing an
integrated primary care programme to
prevent heart attack, stroke and kidney
failure, using blood pressure as an entry
point that address cardiovascular disease and
cervicalcancer in all low- and middle-
income countries is estimated to be US$ 9.4
billion a year
62
Availability of basic technologies to manage
people with hypertension .
Availability and appropriate use of essential
medicines to prevent complications in people
with moderate to high cardiovascular risk .
The links between different levels of the
health system so that people can be
managed appropriately based on heir level of
risk.
63
The basic diagnostic technologies required
for addressing hypertension include accurate
blood pressure measurement devices,
weighing scales, urine albumin strips, fasting
blood sugar tests and blood cholesterol
tests.
64
Not all patients diagnosed with hypertension
require medication but those at medium to
high risk will need one or more of eight essen-
tial medicines to lower their cardiovascular
risk.
65
The cost of implementing such a programme
is low, at less than US$ 1 per head in low-
income countries, less than US$ 1.50 per
head in lower middle-income countries and
US$ 2.50 in up- per middle-income countries
66
Most cardiovascular disease in the population
occurs in people with an average risk level, because
they constitute the largest proportion of the
population.
67
Population-wide approaches to reduce high blood
pressure are similar to those that address other
major non communicable diseases.
They require public policies to reduce the exposure
of the whole population to risk factors such as an
unhealthy diet, physical inactivity, harmful use of
alcohol and tobacco use , with a special focus on
children, adolescents and youth.
68
WHO considers work place health programmes to
be one of the most cost-effective
69
National surveillance health information systems
must be strengthened to monitor the impact of
action to prevent and control hypertension and
other risk factors of non communicable diseases.
70
National
of Programme
Diabetes, for Prevention
Cardiovascular and and
Diseases Control
th
Stroke (NPDCS) was launched on 4 Jan 2008
Objectives
1. Risk reduction for prevention of NCDs
(Diabetes, CVD and Stroke)
2. Early diagnosis and appropriate management of
Diabetes, Cardiovascular Diseases,cancer and
Stroke
71
1. Health Promotion for the General Population
2. Disease Prevention for the High Risk
groups.
72
Awareness generated on HEALTHY LIFE
STYLES.
Decrease in the incidence of Non –
Communicable Diseases particularly,
Diabetes, Cardiovascular Diseases,cancer and
Stroke.
73
A. At Sub centre
74
1. Prevention and health promotion including
counseling
75
1. Investigations: Blood Sugar, lipid profile,
Kidney Function Test (KFT),Liver Function Test
( LFT), ECG, Ultrasound, X ray, colonscopy ,
mammography etc. (if not available, will be
outsourced)
2. Medical management of cases ( out patient ,
inpatient and intensive Care )
3.Follow up and care of bed ridden cases
4.Day care facility
76
A combination increased
of physical
activity, moderation in
alcohol intake, and consumption of
an eating plan that is lower in
sodium content and higher in
fruits, vegetables and low fat dairy
products represents the best
approach for preventing high
blood pressure in the general
population and in high risk groups.
77
a. For persons over age 50, SBP is a
more
important than DBP as CVD risk
factor.
81
13. NATIONAL PROGRAMME FOR PREVENTION AND
CONTROL OF CANCER,DIABETES,
ARDIOVASCULAR DISEASES & STROKE ,(NPCDCS),2004
14. R Deepa et al.Is the ‘Rule of Halves’ in Hypertension Still
Valid? -Evidence from the Chennai Urban Population Study.
JAPI • VOL. 51 • FEBRUARY 2003.
15. Institute of Medicine. Dietary reference intakes for water,
potassium, sodium chloride, and sulfate. Washington, DC:
National Academies Press; 2004.
16. The Framingham Heart Study’s Impact on Global Risk
Assessment. Asaf Bitton, Thomas Gaziano Prog Cardiovasc
Dis. Author manuscript; available in PMC 2011 July 1.
82
83